Next product.

[anonymous]

When is our next product coming? I feel like we’ve been hearing its soon from management for years and just hot air at this point. Radius looks like it added a real dud for their second product after the Gurnet Capital buy out. Maybe our expectations should be low?

 

[anonymous]

They took this long and were picky just to end up buying a branded, expensive Flonase

 

[anonymous]

They took this long and were picky just to end up buying a branded, expensive Flonase

Optinose was a massive failure.

 

[anonymous]

Optinose was a massive failure.

Adam says we can do a better job because of our relationships with internal medicine… were they not calling on internal medicine? Also what percent of Nuzyra business even comes from them?

 

[anonymous]

Adam says we can do a better job because of our relationships with internal medicine… were they not calling on internal medicine? Also what percent of Nuzyra business even comes from them?

The majority of Nuzyra business comes from podiatry. IM’s are minuscule in terms of market share. This is another goat rodeo from the brain surgeons who run this company.

 

[anonymous]

Remember that you have to come up with something to justify your job. Xhance/Optinose is a very expensive version of OTC Flonase, which itself has cheaper store brand versions. It is the Dud of Duds. Optinose tried every angle for ten years and spent about a billion. But, since you are smarter, you will find a way to grow it with little investment.

 

[anonymous]

Remember that you have to come up with something to justify your job. Xhance/Optinose is a very expensive version of OTC Flonase, which itself has cheaper store brand versions. It is the Dud of Duds. Optinose tried every angle for ten years and spent about a billion. But, since you are smarter, you will find a way to grow it with little investment.

Worst acquisition of a product I've seen in a while. This isn't going to end well.